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Abstract 
The prevalence of Chlamydia trachomatis infection in Southern Europe is poorly understood and its identification 
is essential for the design of appropriate prevention policies. The prevalence of C. trachomatis in 2011–2014 was 
determined through polymerase chain reaction in urine samples from 11,687 unselected parturient women from 
the Basque Country, Spain (San Sebastián area). The overall age‑adjusted prevalence was 1.0 % (95 % CI 0.8–1.2). The 
prevalence of infection in women younger than 25 years was 6.4 % and decreased substantially with increasing age: 
2.0 % in 25–29 year‑olds and 0.5 % in older women (P < 0.001). The prevalence was higher in parturient of foreign 
origin (1.9 %, 95 % CI 1.3–2.5) than in Spanish parturients (0.8 %, 95 % CI 0.6–1.0), (P < 0.001). The results of this study 
support the need to screen young women as part of antenatal care in Spain.
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Background
Chlamydia trachomatis (C. trachomatis) is the most 
diagnosed sexually transmitted bacterial infection world-
wide, with an estimated 100 million new infections each 
year (WHO 2012). Chlamydial infections in women fre-
quently cause cervicitis and urethritis, but it has been 
estimated that up to 70–75 % of the cases are asympto-
matic. Asymptomatic infection facilitates its spread to 
sexual contacts and can cause serious sequelae, including 
pelvic inflammatory disease, tubal damage, ectopic preg-
nancy, and infertility (Cates and Wasserheit 1991; Hag-
gerty et al. 2010). In pregnant women, the infection has 
been associated with adverse pregnancy outcomes such 
as prematurity, and may be transmitted vertically to the 
newborn, which may result in neonatal ocular or respir-
atory tract infection (Blas et  al. 2007; Rours et  al. 2011; 
Hammerschlag 2011).
The knowledge of the prevalence of the C. trachoma-
tis infection is essential for the design of appropriate 
infection control programs. In most countries of South-
ern Europe, the prevalence of C. trachomatis infection 
in pregnant women is not well characterized. Moreover, 
even though these women are a potential target group 
for prevention policies (ECDC 2014; CDC et  al. 2014; 
Böhm et al. 2009), to date no recommendation has been 
made in Spain in this regard. The aim of this study was 
to estimate the prevalence of C. trachomatis infection in 
an unselected population of pregnant women at term, by 
age-group and geographical area of origin, in the Basque 
Country, Spain.
Methods
The study was conducted in the city of San Sebastián 
and surrounding counties (413,000 inhabitants, with 
4000–4500 deliveries per year). Eighty-seven percent of 
parturient women in the area attended Donostia Univer-
sity Hospital, the remainder attended private health care 
facilities.
The presence of C. trachomatis was determined in urine 
samples (first catch) collected from unselected parturient 
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women who delivered a live neonate in the Donostia 
University Hospital between January 2011 and Decem-
ber 2014. C. trachomatis determination was included in 
a previously established free-of-charge prevention pro-
gram for sexually-transmitted diseases in our hospital, 
which included serological detection of Treponema palli-
dum and human immunodeficiency virus (HIV). Women 
were informed about C. trachomatis infections and were 
screened in the immediate postpartum period, unless 
they refused to participate. Samples were preserved at 
4 °C until processing, which was carried out within 48 h. 
C. trachomatis DNA was detected using a real-time PCR 
(Cobas® 4800 CT/NG, Roche Diagnostics, Branchburg, 
NJ, USA), which also detects Neisseria gonorrhoeae 
DNA. Samples with an invalid result (no amplification of 
the internal control) were diluted appropriately and were 
re-analyzed. Detection of antibodies against Treponema 
pallidum and HIV was performed with a chemilumi-
nescent microparticle immunoassay (CMIA) (Architect 
Syphilis TP reagent, and Architect HIV Ag/Ab Combo, 
Abbott Laboratories, Wiesbaden, Germany). Treponema 
CMIA-positive samples were reanalyzed using fluores-
cent treponemal antibody absorption (FTA-Abs) (Bio-
Mèrieux, Marcy l´Ètoile, France) and Venereal Disease 
Research Laboratory (VDRL) (Siemens, Marburg, Ger-
many) tests. Upon detection of C. trachomatis infection, 
women were referred to a gynecologist for treatment 
(azithromycin 1  g orally), as well as treatment of their 
sexual partners, if applicable. Similarly, their newborns 
were placed under medical and microbiological surveil-
lance (medical examination and pharyngeal exudate 
7–10 days after birth).
The prevalence of infection and its 95  % exact bino-
mial confidence interval (CI) were calculated based on 
the number of Chlamydia-positive women (numerator) 
and on the number of women with a valid result of the 
diagnostic test (denominator). To estimate the prevalence 
according to the women’s geographical origin (native or 
foreign immigrant), the country of origin in all Chla-
mydia-positive women and in a sample of 1124 parturi-
ent women of the study was identified. As the proportion 
of immigrants vary widely with age, this sample was cho-
sen by stratified random sampling in the four age-groups 
in which was divided the population of the study (sample 
size estimated with 5  % precision and 95  % confidence 
interval for each age-group) using as reference popula-
tion that of parturient women from the Basque Country 
classified by age and country of origin, provided by the 
Basque Institute of Statistics. The distribution by coun-
tries found in the 1124 women was extrapolated to the 
population of women investigated. The overall preva-
lences were age-adjusted in relation to the distribution 
by the age of the total number of parturients in the area 
(Basque Institute of Statistics). The Chi square test was 
used to compare percentages with application of Fisher’s 
corrections (two-tailed), when required. A P value of 
<0.05 was considered statistically significant. The study 
was approved by the Ethics Committee for Clinical 
Research of the Health Area of Gipuzkoa.
Results
Samples were analysed from 12,228 parturient women 
(median age 33 years, range 14–54), representing 76.4 % 
of the eligible population screened (84.6  % in the last 
three years). The result was invalid (inhibition of inter-
nal control amplification) in 541/12,228 samples (4.4 %), 
corresponding mostly to haematuric urine samples. C. 
trachomatis was detected in 121/11,687 women, with an 
overall age-standardized prevalence of 1 % (95 % CI 0.8–
1.2) and an annual prevalence ranging from 1.2 % in 2011 
to 0.8 % in 2013 (P = 0.14, non-significant). The median 
age of C. trachomatis–positive women was 27  years, 
range 17–43.
The prevalence of infection was higher in younger 
women, being 6.4  % in those aged <25  years, and 
decreased with increasing age: 2.0  % in 25–29  year-
olds and 0.5 % in women aged ≥30 years old (P < 0.001) 
(Table  1). Women aged <25 and <30  years old repre-
sented 5.1 and 20.5 % of parturient women but accounted 
for 31.4 and 60.3  % of detected cases, respectively. 
Overall and in all age groups, prevalence was higher in 
immigrant than in Spanish parturient women [overall 
age-standardized prevalence 1.9 % (95 % CI 1.3–2.5) vs. 
0.8 % (95 % CI 0.6–1.0) respectively, P < 0.001] (Table 1). 
Parturient women of Latin American origin had the 
highest prevalence (4.9  %) and they also were the main 
group of population among immigrants (43 %), account-
ing for 37.2 % of all infected women and 78.9 % (n = 45) 
of infected immigrants. The estimated prevalence in 
women of North African origin, the second largest immi-
grant group in Spain, was 1 % in this study (4/418).
Neither Neisseria gonorrhoeae nor current Treponema 
pallidum infection (VDRL positive) was detected in any 
of the 11,687 parturient women, although 27 women 
(0.2 %) (one of whom was Chlamydia-infected) had a his-
tory of syphilis (CMIA/FTA-Abs positive). Seven women 
(0.1  %) had HIV infection but none of these was coin-
fected with C. trachomatis. Only two Chlamydia-positive 
patients had symptoms attributable to the infection dur-
ing pregnancy (one woman with cervicitis at week 25 and 
another with dysuria, leukocyturia and negative urine 
culture in week 36). A further four women had nonspe-
cific symptoms of doubtful interpretation (vulvovaginal 
pruritus and/or vaginal discharge). The prevalence of 
preterm birth (neonates less than 37 weeks of gestational 
age) in Chlamydia-positive mothers was 7.6  % (n =  9). 
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Perinatal transmission was detected in 10/91 (11 %) neo-
nates studied. Four of them were symptomatic and pre-
sented conjunctivitis.
Discussion
The present study was conducted in the immedi-
ate postpartum of women representative of the full-
term pregnant women in our region that attended 
public healthcare. The median age at delivery in the 
San Sebastián area was high, which may explain why 
the overall prevalence of infection was considerably 
lower than in pregnant women from central and north-
ern European countries (1 vs. 2–3.9  %) (Rours et  al. 
2011; Böhm et al. 2009; McMillan et al. 2006; Oakeshott 
et al. 2002; Kirk et al. 2008; Peuchant et al. 2015). As in 
most studies, the prevalence of infection in this study 
was higher in younger women. The prevalence of infec-
tion among women younger than 25  years (6.4  %) was 
closer to that found in the previously-mentioned Euro-
pean studies, showing figures somewhat higher than in 
Germany (4.5–5.7  %) (Böhm et  al. 2009) but somewhat 
lower than in France (7.9  %) (Peuchant et  al. 2015), the 
United Kingdom (8.6–8.7 %) (Oakeshott et al. 2002; Kirk 
et  al. 2008), Eire (8.7  %) (McMillan et  al. 2006) and the 
Netherlands (9.1  %) (Rours et  al. 2011). The prevalence 
decreased sharply in older parturient women participat-
ing in this survey, which could partly be because women 
tend to have fewer partners as they get older. No N. gon-
orrhoeae infection was found in this large group, similar 
to the results recently obtained in the South of France in 
a group of 1004 pregnant women (Peuchant et al. 2015) 
and in Northern Italy among 2099 sexually active adoles-
cents (Matteelli et al. 2016).
Information on the prevalence of C. trachomatis infec-
tion in the sexually-active general population in Spain is 
very scarce, since only one population-based study, lim-
ited to a town in the region of Asturias, has been con-
ducted in the last decade (Fernández-Benítez et al. 2013). 
In that study, the prevalence of infection among sexually-
active women younger than 25  years (4  %, range 2.8–
6.4 %) was fairly similar to that observed in the present 
study. The prevalence of infection was higher in immi-
grant women as a whole, and especially in women of 
Latin American origin, who represent the main source of 
migration to Spain. These findings were probably related 
to the higher infection rates in their countries of origin 
(Cabeza et al. 2015; Pinto et al. 2011). Migration to Spain 
is a relatively recent event and, in studies conducted in 
other populations in Spain, has been considered an inde-
pendent risk factor for C. trachomatis infection (Corbeto 
et al. 2010).
The study has some limitations. Because of the large 
number of pregnant women included in this study, no 
data on sexual activity were collected prospectively. 
Moreover, using nucleic acid amplification tests, the sen-
sitivity of first catch urine specimens to detect C. tra-
chomatis might be somewhat lower (up to 10 %) than that 
obtained from the vagina or cervix (CDC et  al. 2014). 
Therefore the prevalence of C. trachomatis in women in 
Gipuzkoa could be slightly higher than that found in this 
study. However, first catch urine is an acceptable sam-
ple for the diagnosis of C. trachomatis urogenital infec-
tions in women (CDC et al. 2014), it is commonly used 
for C. trachomatis screening during pregnancy (Satter-
white et  al. 2012; Böhm et  al. 2009) and has been used 
in prevalence studies (Rours et al. 2011; McMillan et al. 
Table 1 Prevalence of C. trachomatis infection by age and country of origin in puerperal women from the San Sebastián 
area, Basque Country, Spain (2011–2014)
a Median age 33 years, range 14–54
b Number estimated on the basis of randomized stratified sampling in women giving birth in the Donostia University Hospital during the study period (see 
“Methods”). The origin of Chlamydia-positive women was individually collected after their detection in screening
c Prevalence was 9.6 % (95 % CI 5.6–16.0) (12/125) and 5.5 % (95 % CI 3.8–8.0) (26/471) in women younger than 20 years and those aged 20–24 years old, respectively
d Fisher exact test (two tailed)
e Age-adjusted prevalence was 1.0 % (95 % CI 0.8–1.2) for the entire group and was 0.8 % (95 % CI 0.6–1.0) and 1.9 % (95 % CI 1.3–2.5) for native women and foreign 
immigrants, respectively, Chi square = 20.54, P < 0.001
Agea (years) Total Native Foreign immigrants P
No. CT+ (%) (95 % CI) No.b CT+ (%) (95 % CI) No.b CT+ (%) (95 % CI)
<25 596 38 (6.4)c (4.7–8.6) 247 14 (5.7) (3.4–9.3) 349 24 (6.9) (4.7–10.0) 0.552
25–29 1799 35 (2.0) (1.4–2.7) 1164 16 (1.4) (0.9–2.2) 635 19 (3.0) (1.9–4.6) 0.018
30–34 4710 26 (0.6) (0.4–0.8) 4065 18 (0.4) (0.3–0.7) 645 8 (1.2) (0.6–2.4) 0.019d
≥35 4582 22 (0.5) (0.3–0.7) 4073 16 (0.4) (0.2–0.6) 509 6 (1.2) (0.6–2.5) 0.029d
Total 11,687 121 (1.0)e (0.9–1.2) 9549 64 (0.7) e (0.5–0.8) 2138 57 (2.7)e (2.1–3.4) <0.001
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2006). In addition, although lower percentages of invalid 
results have been referred by other authors (Rockett et al. 
2010) they did not test urine specimens from postpar-
tum women, among which haematuric urines are com-
mon. The percentage of invalid tests in our study (4.4 %) 
was similar to that found in another study in parturient 
women from Brazil (Pinto et al. 2011) in which 3.7 % of 
women were excluded because of bleeding during sam-
ple collection. Finally, although women were warned that 
urine collection should be first catch, we cannot ensure 
that it was the collected sample in all cases.
The most effective measure to control C. trachoma-
tis infection is population-based screening in adoles-
cents and young adults, but it is difficult to implement 
(ECDC 2014). An additional policy is screening in preg-
nancy. This form of screening is easy to implement and 
can achieve high coverage, since pregnant women usu-
ally make use of prenatal care and are usually willing 
to undergo diagnostic tests that could prevent adverse 
pregnancy outcomes. Pregnancy-based screening would 
detect infected women who are therefore at risk of preg-
nancy complications, and of transmitting the infection 
to their infants during delivery (Rours et al. 2011; Ham-
merschlag 2011; ECDC 2014; CDC et al. 2010). Most of 
these women are asymptomatic and their infection would 
remain undetected without screening. In this context, the 
high prevalence observed in young women in this study 
supports the need to recommend C. trachomatis screen-
ing in pregnant women ≤25 years during their first gesta-
tional control visit in this region of Spain and the possible 
broadening of this strategy to women aged 25–29 years.
Conclusion
The results of this large study show that prevalence of C. 
trachomatis infection was high among pregnant women 
younger than 25 years (6 %). C. trachomatis infection rep-
resents a significant public health problem in this South-
ern European region. A gestational screening should be 
implemented in young women as part of antenatal care 
in Spain.
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